Reimagining nail health: The next frontier in dermatologic innovation.
- 1Department of Dermatology, New York University School of Medicine, New York, New York, USA.
- 2Wellman Center for Photomedicine, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Abstract
Nail disorders are a frequently overlooked aspect of dermatology despite their effects on function, appearance, and QOL. Although artificial intelligence (AI)-driven skin analysis tools have advanced rapidly for acne, pigmentation, lesion classification, and melanoma risk assessment, the nail unit remains underrepresented in validated digital dermatology platforms. This gap limits early diagnosis, objective monitoring, and treatment assessment for conditions including onychomycosis, nail psoriasis, longitudinal melanonychia, and traumatic nail dystrophies. This review examines current AI-enabled dermatology platforms, identifies gaps in nail assessment, and proposes a framework for future nail-focused computational imaging. Published studies and publicly available platforms were evaluated for imaging methods, analytic capabilities, validation, and clinical relevance. Skin-focused AI systems demonstrate image analysis techniques applicable to nail disease, yet most consumer nail applications remain cosmetic. Emerging studies support the feasibility of AI-assisted nail imaging, but they are limited by small datasets, retrospective designs, limited external validation, and underrepresentation of diverse skin tones and nail morphologies. Standardized nail photography, expert-annotated datasets, explainable AI, prospective validation, and teledermatology integration are needed to translate AI-assisted nail assessment into clinically useful tools and advance precision digital dermatology.
Related
- Reimagining Indian Dentistry: Reforming Education, Workforce, and Oral Health Delivery
- Reimagining social prescribing for climate-resilient and equitable urban health systems
- Evaluating the robustness and readiness of large frontier models in health AI applications
- Biophotonics in oral health: bridging light-based innovation and clinical practice
- Flipping the script: co-creation and local innovation in AI for global health paradigms
BibTeX
@article{ishack2026reimagining,
title = {{Reimagining nail health: The next frontier in dermatologic innovation.}},
author = {Stephanie Ishack and Lilit Garibyan},
journal = {JID innovations : skin science from molecules to population health},
year = {2026},
month = sep,
doi = {10.1016/j.xjidi.2026.100531},
url = {https://europepmc.org/article/MED/42927083},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Reimagining nail health: The next frontier in dermatologic innovation.
AU - Stephanie Ishack
AU - Lilit Garibyan
PY - 2026
DA - 2026/09/24
JO - JID innovations : skin science from molecules to population health
DO - 10.1016/j.xjidi.2026.100531
UR - https://europepmc.org/article/MED/42927083
AB - Nail disorders are a frequently overlooked aspect of dermatology despite their effects on function, appearance, and QOL. Although artificial intelligence (AI)-driven skin analysis tools have advanced rapidly for acne, pigmentation, lesion classification, and melanoma risk assessment, the nail unit remains underrepresented in validated digital dermatology platforms. This gap limits early diagnosis, objective monitoring, and treatment assessment for conditions including onychomycosis, nail psoriasis, longitudinal melanonychia, and traumatic nail dystrophies. This review examines current AI-enabled dermatology platforms, identifies gaps in nail assessment, and proposes a framework for future nail-focused computational imaging. Published studies and publicly available platforms were evaluated for imaging methods, analytic capabilities, validation, and clinical relevance. Skin-focused AI systems demonstrate image analysis techniques applicable to nail disease, yet most consumer nail applications remain cosmetic. Emerging studies support the feasibility of AI-assisted nail imaging, but they are limited by small datasets, retrospective designs, limited external validation, and underrepresentation of diverse skin tones and nail morphologies. Standardized nail photography, expert-annotated datasets, explainable AI, prospective validation, and teledermatology integration are needed to translate AI-assisted nail assessment into clinically useful tools and advance precision digital dermatology.
SN - 2667-0267
ER -